NALE & peptide GНАЛЭ
An experimental version of Leu-enkephalin designed to study cell protection without conventional opioid activity. The profile also covers peptide G.
What the studies found
Animal research · 1994
NALE and Hydra morphogen
- Non-opioid analogue plus hypoxia
- Offspring tracheal DNA synthesis reportedly restored; neonatal lung catalase and superoxide-dismutase activity reportedly returned toward control levelsQualitative/narrative extraction; per-group n and precise uncertainty not authenticated
- Hydra morphogen alone: adverse direction
- Tracheal epithelial DNA synthesis and part of antioxidant defense were suppressed in uninjured offspringThis is a different experimental peptide, not an effect assigned to NALE
- Neutral assay findings
- Glutathione reductase and glutathione transferase did not differ significantly across experimental groupsNo universal improvement across all antioxidant endpoints
Maternal non-opioid Leu-enkephalin analogue exposure reportedly restored offspring tracheal DNA synthesis after prenatal hypoxia and changed lung redox measures. The distinct Hydra morphogen inhibited tracheal DNA synthesis in uninjured offspring. Sequence transcription and full-thesis tables need authentication.
Study notes · methods, sources and limitations
Participants or model Author abstract describes 700 experiments on neonatal offspring of 160 dams; these are not 700 independent pregnancies. Treatment-specific dam/pup denominators unavailable.
Design Four exposure conditions for each peptide: uninjured, prenatal hypoxia, peptide alone, peptide plus hypoxia. Daily maternal hypoxia on gestation days 14–19; offspring examined 24 hours after birth. Separate non-opioid analogue and Hydra morphogen arms.
Important limitations
- Historical maternal animal study; no human pregnancy efficacy or safety established.
- Historical maternal animal study; no human pregnancy efficacy or safety established. Third-party OCR transcription, not an authenticated 147-page thesis. Tables and peptide sequences contain OCR ambiguity; no precise table cells are treated as visually verified. NALE is a non-opioid analogue, distinct from Dalargin. The transcription prints a third residue resembling Glu, while later NALE sources specify Gly; exact preparation identity remains unresolved. The 1994 journal report may describe the same experiments. Hydra morphogen has no interchangeable compound-card assignment.
Candidate dissertation author’s abstract. Khabarovsk, 1994; respiratory-system DNA synthesis and lipid peroxidation after prenatal hypoxia · Dissertation author-abstract transcription
Lab research · 2021
Role of Amino Acid Arginine and Nitric Oxide in Mechanisms of Cytoprotective Effect of Non-Opiate Leu-Enkephalin Analogue In Vitro.
- NALE superoxide generation
- 20.7% reduction
- NALE p53-positive cells
- 40.2% reduction
- NALE + L-NAME p53-positive cells
- 65.3% reduction
NALE and the C-terminal Gly comparator peptide G reduced oxidative-injury markers. NO-synthase inhibition did not remove protection, arguing against an essential role for terminal Arg or NO-synthase activation in this cell model.
More reported outcomes
- Peptide G p53-positive cells
- 73.5% reduction
- Peptide G superoxide generation
- 18.4% reduction
Study notes · methods, sources and limitations
Participants or model Primary pulmonary fibroblast cultures
Design Pulmonary-fibroblast cultures; NALE or peptide G 0.1 microM; peroxide injury 60 microM; L-NAME 1 mM in combination assays.
Important limitations
- Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.
- NALE and peptide G are distinct preparations; cell-survival markers are not clinical effects.
Bulletin of experimental biology and medicine · Indexed abstract
Lab research · 2026
Cytoprotective Effect of NOP Receptor Blockade in Primary Culture of Pulmonary Fibroblasts.
NALE retained cytoprotective effects during NOP-receptor blockade. Some combined measures improved further, so earlier proposals of NOP mediation remain unresolved rather than established.
Study notes · methods, sources and limitations
Participants or model Primary pulmonary fibroblasts under oxidative stress
Important limitations
- Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.
Bulletin of experimental biology and medicine · Indexed abstract
About NALE & peptide G
Names in this research collection
NALE · Phe-D-Ala-Gly-Phe-Leu-Arg · Peptide G
Research background
An experimental non-opiate leu-enkephalin analogue used to investigate cytoprotection apart from conventional opioid effects.
Pregnancy and offspring research
Maternal non-opioid Leu-enkephalin analogue exposure reportedly restored offspring tracheal DNA synthesis after prenatal hypoxia and changed lung redox measures. The distinct Hydra morphogen inhibited tracheal DNA synthesis in uninjured offspring. Sequence transcription and full-thesis tables need authentication.
Historical maternal animal study; no human pregnancy efficacy or safety established.
Reported findings and methods ↗ · Pregnancy research: full evidence review and archive ↗
- Compound class
- Peptide research family
- Research collection
- Opioid-peptide cytoprotection · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
No human treatment trial assessed for this family
Study methods
Member-specific studies; patents and archival leads identified separately
Independent replication
Independent replication not established by the records collected here
Source access
Primary abstracts, selected full texts, patents and explicit retrieval targets
Safety evidence
Cell and animal effects do not establish human safety; analogues may differ
Open a topic for the evidence assessment.
Findings by study
Animal research · 1994
NALE and Hydra morphogen: maternal exposure and offspring lung findings
Maternal non-opioid Leu-enkephalin analogue exposure reportedly restored offspring tracheal DNA synthesis after prenatal hypoxia and changed lung redox measures. The distinct Hydra morphogen inhibited tracheal DNA synthesis in uninjured offspring. Sequence transcription and full-thesis tables need authentication.
Study notes and original source
NALE and Hydra morphogen: maternal exposure and offspring lung findings
Experimental non-opioid Leu-enkephalin analogue (NALE label; exact sequence unresolved), separate Hydra morphogen arm · Dissertation author-abstract transcription
Format: Dissertation author-abstract transcription · Reviewed: Medical-Diss author-abstract transcription; selected methods, narrative results and source limitations checked; original full thesis not recovered
O. A. Lebedko · Candidate dissertation author’s abstract. Khabarovsk, 1994; respiratory-system DNA synthesis and lipid peroxidation after prenatal hypoxia
Maternal non-opioid Leu-enkephalin analogue exposure reportedly restored offspring tracheal DNA synthesis after prenatal hypoxia and changed lung redox measures. The distinct Hydra morphogen inhibited tracheal DNA synthesis in uninjured offspring. Sequence transcription and full-thesis tables need authentication.
Results and tables
Reported findings and study design
Reported findings
Maternal non-opioid Leu-enkephalin analogue exposure reportedly restored offspring tracheal DNA synthesis after prenatal hypoxia and changed lung redox measures. The distinct Hydra morphogen inhibited tracheal DNA synthesis in uninjured offspring. Sequence transcription and full-thesis tables need authentication.
Four exposure conditions for each peptide: uninjured, prenatal hypoxia, peptide alone, peptide plus hypoxia. Daily maternal hypoxia on gestation days 14–19; offspring examined 24 hours after birth. Separate non-opioid analogue and Hydra morphogen arms.
Population or model Author abstract describes 700 experiments on neonatal offspring of 160 dams; these are not 700 independent pregnancies. Treatment-specific dam/pup denominators unavailable.
Dose, route and schedule
Non-opioid Leu-enkephalin analogue or Hydra peptide morphogen 10 µg/kg intraperitoneally to dams 30 minutes before daily hypoxic exposure on gestation days 14–19. Day-1 offspring tracheal DNA-synthesis and lung/blood redox assays. Experimental methods, not a human pregnancy regimen.
Protocol source ↗ · Medical-Diss author-abstract transcription; selected methods, narrative results and source limitations checked; original full thesis not recovered
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Non-opioid analogue plus hypoxia | Offspring tracheal DNA synthesis reportedly restored; neonatal lung catalase and superoxide-dismutase activity reportedly returned toward control levels | Qualitative/narrative extraction; per-group n and precise uncertainty not authenticated |
| Hydra morphogen alone: adverse direction | Tracheal epithelial DNA synthesis and part of antioxidant defense were suppressed in uninjured offspring | This is a different experimental peptide, not an effect assigned to NALE |
| Neutral assay findings | Glutathione reductase and glutathione transferase did not differ significantly across experimental groups | No universal improvement across all antioxidant endpoints |
Historical maternal animal study; no human pregnancy efficacy or safety established. Third-party OCR transcription, not an authenticated 147-page thesis. Tables and peptide sequences contain OCR ambiguity; no precise table cells are treated as visually verified. NALE is a non-opioid analogue, distinct from Dalargin. The transcription prints a third residue resembling Glu, while later NALE sources specify Gly; exact preparation identity remains unresolved. The 1994 journal report may describe the same experiments. Hydra morphogen has no interchangeable compound-card assignment.
Source for these results ↗ · Reviewed 2026-11-08
- Population / setting
- Author abstract describes 700 experiments on neonatal offspring of 160 dams; these are not 700 independent pregnancies. Treatment-specific dam/pup denominators unavailable.
- Source reviewed
- Medical-Diss author-abstract transcription; selected methods, narrative results and source limitations checked; original full thesis not recovered
Study limitations
- Historical maternal animal study; no human pregnancy efficacy or safety established.
- Third-party OCR transcription, not an authenticated 147-page thesis. Tables and peptide sequences contain OCR ambiguity; no precise table cells are treated as visually verified.
- NALE is a non-opioid analogue, distinct from Dalargin. The transcription prints a third residue resembling Glu, while later NALE sources specify Gly; exact preparation identity remains unresolved.
- The 1994 journal report may describe the same experiments. Hydra morphogen has no interchangeable compound-card assignment.
Reviewed 2026-11-08.
Lab research · 2021
Role of Amino Acid Arginine and Nitric Oxide in Mechanisms of Cytoprotective Effect of Non-Opiate Leu-Enkephalin Analogue In Vitro.
NALE and the C-terminal Gly comparator peptide G reduced oxidative-injury markers. NO-synthase inhibition did not remove protection, arguing against an essential role for terminal Arg or NO-synthase activation in this cell model.
NALE superoxide generation · 20.7% reduction
Study notes and original source
Role of Amino Acid Arginine and Nitric Oxide in Mechanisms of Cytoprotective Effect of Non-Opiate Leu-Enkephalin Analogue In Vitro.
Sazonova EN, Lebed'ko OA, Pinaeva OG, Tsimbalist NA, Kupriyanova DA, Tarasov PK, Malofey YB · Bulletin of experimental biology and medicine
NALE and the C-terminal Gly comparator peptide G reduced oxidative-injury markers. NO-synthase inhibition did not remove protection, arguing against an essential role for terminal Arg or NO-synthase activation in this cell model.
Results and tables
Reported findings and study design
Pulmonary-fibroblast cultures; NALE or peptide G 0.1 microM; peroxide injury 60 microM; L-NAME 1 mM in combination assays.
Population or model Primary pulmonary fibroblast cultures
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| NALE superoxide generation | 20.7% reduction | |
| NALE p53-positive cells | 40.2% reduction | |
| NALE + L-NAME p53-positive cells | 65.3% reduction | |
| Peptide G p53-positive cells | 73.5% reduction | |
| Peptide G superoxide generation | 18.4% reduction |
NALE and peptide G are distinct preparations; cell-survival markers are not clinical effects.
Source for these results ↗ · Reviewed 2026-10-29
- Population / setting
- Primary pulmonary fibroblast cultures
- Source reviewed
- Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Reviewed 2026-10-05.
Lab research · 2026
Cytoprotective Effect of NOP Receptor Blockade in Primary Culture of Pulmonary Fibroblasts.
NALE retained cytoprotective effects during NOP-receptor blockade. Some combined measures improved further, so earlier proposals of NOP mediation remain unresolved rather than established.
Study notes and original source
Cytoprotective Effect of NOP Receptor Blockade in Primary Culture of Pulmonary Fibroblasts.
Sazonova EN, Repa OG, Malofey YB · Bulletin of experimental biology and medicine
NALE retained cytoprotective effects during NOP-receptor blockade. Some combined measures improved further, so earlier proposals of NOP mediation remain unresolved rather than established.
- Population / setting
- Primary pulmonary fibroblasts under oxidative stress
- Source reviewed
- Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Reviewed 2026-10-05.
Lab research · 2019
Cytoprotective effect of non-opioid leu-enkephalin analogue in primary culture of pulmonary fibroblasts in oxidative stress
NALE reduced oxidative-stress and nucleolar changes in pulmonary fibroblasts. The paper explicitly gives Phe–D-Ala–Gly–Phe–Leu–Arg; its suggested NOP mechanism was a hypothesis.
Study notes and original source
Cytoprotective effect of non-opioid leu-enkephalin analogue in primary culture of pulmonary fibroblasts in oxidative stress
E. N. Sazonova, O. A. Lebedko, G. A. Denisyuk, K. V. Zhmerenetskiy, V. A. Dobrykh · Primary source linked above
NALE reduced oxidative-stress and nucleolar changes in pulmonary fibroblasts. The paper explicitly gives Phe–D-Ala–Gly–Phe–Leu–Arg; its suggested NOP mechanism was a hypothesis.
- Population / setting
- Primary pulmonary fibroblasts
- Source reviewed
- Selected original-source text checked; full methodological review pending.
Study limitations
- In-vitro surrogate outcomes, not clinical recovery.
- Later receptor-blockade work qualifies the proposed mechanism.
Reviewed 2026-10-05.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗